Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 23, 2013 Filed May 23, 2013 21:19 UTC |
Caforio GiovanniPres., US Pharmaceuticals
|
Exercise / conversionOption (right to buy) · Derivative | 21,333 | $0.00 Strike: $25.45 | $0.00 |
DisclosureSEC source: 0001225208-13-013159 · doc4.xml · derivative · entry 3 Caforio Giovanni · CIK 0001533201 · Pres., US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 21,333 shares Expires 2015-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 1, 2005. F2 · derivative.expiration_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 1, 2005. Read SEC document |
| May 23, 2013 Filed May 23, 2013 21:19 UTC |
Caforio GiovanniPres., US Pharmaceuticals
|
SaleCommon Stock, $0.10 par value | 26,647 | $46.29 | $1,233,489.63 |
DisclosureSEC source: 0001225208-13-013159 · doc4.xml · nonDerivative · entry 2 Caforio Giovanni · CIK 0001533201 · Pres., US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,854.219 F1 · shares: The reporting person sold 17,913 shares to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions upon the exercise of the option. The remaining 8,734 shares sold were held by the reporting person for more than a year. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $46.22 to $46.46, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · price: The reporting person sold 17,913 shares to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions upon the exercise of the option. The remaining 8,734 shares sold were held by the reporting person for more than a year. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $46.22 to $46.46, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 23, 2013 Filed May 23, 2013 21:19 UTC |
Caforio GiovanniPres., US Pharmaceuticals
|
Exercise / conversionCommon Stock, $0.10 par value | 21,333 | $25.45 | $542,924.85 |
DisclosureSEC source: 0001225208-13-013159 · doc4.xml · nonDerivative · entry 1 Caforio Giovanni · CIK 0001533201 · Pres., US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,501.219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2013 Filed May 23, 2013 21:20 UTC |
Cazala Beatrice JEVP Commercial Operations
|
Exercise / conversionOption (right to buy) · Derivative | 42,911 | $0.00 Strike: $27.36 | $0.00 |
DisclosureSEC source: 0001225208-13-013160 · doc4.xml · derivative · entry 6 Cazala Beatrice J · CIK 0001457948 · EVP Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 42,911 shares Expires 2016-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 12, 2007. F4 · derivative.expiration_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 12, 2007. Read SEC document |
| May 23, 2013 Filed May 23, 2013 21:20 UTC |
Cazala Beatrice JEVP Commercial Operations
|
Exercise / conversionOption (right to buy) · Derivative | 73,501 | $0.00 Strike: $21.88 | $0.00 |
DisclosureSEC source: 0001225208-13-013160 · doc4.xml · derivative · entry 5 Cazala Beatrice J · CIK 0001457948 · EVP Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 73,501 shares Expires 2017-09-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 7, 2008. F3 · derivative.expiration_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 7, 2008. Read SEC document |
| May 23, 2013 Filed May 23, 2013 21:20 UTC |
Cazala Beatrice JEVP Commercial Operations
|
SaleCommon Stock, $0.10 par value | 96,000 | $46.99 | $4,511,040.00 |
DisclosureSEC source: 0001225208-13-013160 · doc4.xml · nonDerivative · entry 3 Cazala Beatrice J · CIK 0001457948 · EVP Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,656.93 F1 · shares: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $46.96 to $47.03, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $46.96 to $47.03, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 23, 2013 Filed May 23, 2013 21:20 UTC |
Cazala Beatrice JEVP Commercial Operations
|
Exercise / conversionCommon Stock, $0.10 par value | 42,911 | $27.36 | $1,174,044.96 |
DisclosureSEC source: 0001225208-13-013160 · doc4.xml · nonDerivative · entry 2 Cazala Beatrice J · CIK 0001457948 · EVP Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,656.93 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2013 Filed May 23, 2013 21:20 UTC |
Cazala Beatrice JEVP Commercial Operations
|
Exercise / conversionCommon Stock, $0.10 par value | 73,501 | $21.88 | $1,608,201.88 |
DisclosureSEC source: 0001225208-13-013160 · doc4.xml · nonDerivative · entry 1 Cazala Beatrice J · CIK 0001457948 · EVP Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,745.93 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2013 Filed May 20, 2013 20:17 UTC |
CORNELIUS JAMES MDirector
|
Exercise / conversionExecutive Option (right to buy) · Derivative | 205,996 | $0.00 Strike: $22.14 | $0.00 |
DisclosureSEC source: 0001225208-13-012781 · doc4.xml · derivative · entry 5 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock, $0.10 par value · 205,996 shares Expires 2018-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: As Mr. Cornelius had attained age 60, this stock option award vested 100% on the first anniversary of the grant date, which was March 4, 2009. F5 · derivative.expiration_date: As Mr. Cornelius had attained age 60, this stock option award vested 100% on the first anniversary of the grant date, which was March 4, 2009. Read SEC document |
| May 17, 2013 Filed May 20, 2013 20:17 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 205,996 | $42.98 | $8,853,708.08 |
DisclosureSEC source: 0001225208-13-012781 · doc4.xml · nonDerivative · entry 4 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 741,824 F4 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.71 to $43.43, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 17, 2013 Filed May 20, 2013 20:17 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $43.00 | $430,000.00 |
DisclosureSEC source: 0001225208-13-012781 · doc4.xml · nonDerivative · entry 3 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 947,820 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.71 to $43.33, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 17, 2013 Filed May 20, 2013 20:17 UTC |
CORNELIUS JAMES MDirector
|
Exercise / conversionCommon Stock, $0.10 par value | 205,996 | $22.14 | $4,560,751.44 |
DisclosureSEC source: 0001225208-13-012781 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 957,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2013 Filed May 20, 2013 20:17 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $43.24 | $432,400.00 |
DisclosureSEC source: 0001225208-13-012781 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 751,824 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.65 to $44.45, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 08, 2013 Filed May 8, 2013 20:25 UTC |
DANIELS BRIANSVP Global Dev & Med Affairs
|
SaleCommon Stock, $0.10 par value | 15,000 | $39.93 | $598,950.00 |
DisclosureSEC source: 0001225208-13-011656 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,239.041 F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.90 to $39.99, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 08, 2013 Filed May 9, 2013 20:19 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $39.78 | $397,800.00 |
DisclosureSEC source: 0001225208-13-011831 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761,824 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.56 to $40.11, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 07, 2013 Filed May 9, 2013 20:19 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $39.91 | $399,100.00 |
DisclosureSEC source: 0001225208-13-011831 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 771,824 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.66 to $40.16, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 04, 2013 Filed May 7, 2013 22:29 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
Exercise / conversionMarket Share Units · Derivative | 13,989 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-011570 · doc4.xml · derivative · entry 4 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,990 Underlying: Common Stock, $0.10 par value · 13,989 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on May 4, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date. F1 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on May 4, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date. Read SEC document |
| May 04, 2013 Filed May 7, 2013 22:29 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
Tax withholdingCommon Stock, $0.10 par value | 12,754 | $40.20 | $512,710.80 |
DisclosureSEC source: 0001225208-13-011570 · doc4.xml · nonDerivative · entry 3 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 578,562 F3 · shares: Shares withheld for payment of taxes upon vesting of market share units. Read SEC document |
| May 04, 2013 Filed May 7, 2013 22:29 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
OtherCommon Stock, $0.10 par value | 8,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-011570 · doc4.xml · nonDerivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 591,316 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| May 04, 2013 Filed May 7, 2013 22:29 UTC |
ANDREOTTI LAMBERTODirector · Chief Executive Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 13,989 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-011570 · doc4.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 582,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on May 4, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date. Read SEC document |
| May 03, 2013 Filed May 6, 2013 21:45 UTC |
Elicker John ESVP Pub Affairs & Inv Relation
|
Exercise / conversionRestricted Stock Units · Derivative | 1,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-011465 · doc4.xml · derivative · entry 3 Elicker John E · CIK 0001554788 · SVP Pub Affairs & Inv Relation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,509 Underlying: Common Stock, $0.10 par value · 1,508 shares Expires 2014-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: Represents vesting of one-quarter of restricted stock units granted on May 3, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date. F3 · derivative.expiration_date: Represents vesting of one-quarter of restricted stock units granted on May 3, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date. Read SEC document |
| May 03, 2013 Filed May 6, 2013 21:45 UTC |
Elicker John ESVP Pub Affairs & Inv Relation
|
Tax withholdingCommon Stock, $0.10 par value | 679 | $40.20 | $27,295.80 |
DisclosureSEC source: 0001225208-13-011465 · doc4.xml · nonDerivative · entry 2 Elicker John E · CIK 0001554788 · SVP Pub Affairs & Inv Relation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,555.97 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| May 03, 2013 Filed May 6, 2013 21:45 UTC |
Elicker John ESVP Pub Affairs & Inv Relation
|
Exercise / conversionCommon Stock, $0.10 par value | 1,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-011465 · doc4.xml · nonDerivative · entry 1 Elicker John E · CIK 0001554788 · SVP Pub Affairs & Inv Relation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,234.97 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2013 Filed May 2, 2013 21:01 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $39.85 | $398,500.00 |
DisclosureSEC source: 0001225208-13-011042 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 781,824 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.70 to $40.00, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 01, 2013 Filed May 2, 2013 20:23 UTC |
Moed Samuel JSVP, Strat Plan & Analysis
|
Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-011021 · doc4.xml · derivative · entry 5 Moed Samuel J · CIK 0001561017 · SVP, Strat Plan & Analysis 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock, $0.10 par value · 5,000 shares Expires 2014-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: Represents vesting of one-third of restricted stock units granted on May 1, 2009. The balance of the award is scheduled to vest on the fifth anniversary of the grant date. F3 · derivative.expiration_date: Represents vesting of one-third of restricted stock units granted on May 1, 2009. The balance of the award is scheduled to vest on the fifth anniversary of the grant date. Read SEC document |
| May 01, 2013 Filed May 2, 2013 20:23 UTC |
Moed Samuel JSVP, Strat Plan & Analysis
|
Tax withholdingCommon Stock, $0.10 par value | 2,269 | $39.72 | $90,124.68 |
DisclosureSEC source: 0001225208-13-011021 · doc4.xml · nonDerivative · entry 2 Moed Samuel J · CIK 0001561017 · SVP, Strat Plan & Analysis 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,485.464 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| May 01, 2013 Filed May 2, 2013 20:23 UTC |
Moed Samuel JSVP, Strat Plan & Analysis
|
Exercise / conversionCommon Stock, $0.10 par value | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-011021 · doc4.xml · nonDerivative · entry 1 Moed Samuel J · CIK 0001561017 · SVP, Strat Plan & Analysis 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,754.464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2013 Filed May 2, 2013 21:01 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $39.66 | $396,600.00 |
DisclosureSEC source: 0001225208-13-011042 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 791,824 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.25 to $39.81, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 30, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionExecutive Option (right to buy) · Derivative | 202,405 | $0.00 Strike: $24.74 | $0.00 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · derivative · entry 24 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock, $0.10 par value · 202,405 shares Expires 2016-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: One-third of the stock option award vested on each of the third, fourth and fifth anniversaries of the grant date, which was December 1, 2006. F9 · derivative.expiration_date: One-third of the stock option award vested on each of the third, fourth and fifth anniversaries of the grant date, which was December 1, 2006. Read SEC document |
| April 30, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionExecutive Option (right to buy) · Derivative | 103,500 | $0.00 Strike: $25.45 | $0.00 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · derivative · entry 23 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 103,500 shares Expires 2015-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third and fourth anniversaries of the grant date, which was March 1, 2005. F10 · derivative.expiration_date: Twenty-five percent of the stock option award vested on each of the first, second, third and fourth anniversaries of the grant date, which was March 1, 2005. Read SEC document |
| April 30, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
SaleCommon Stock, $0.10 par value | 459 | $39.65 | $18,199.35 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 18 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Indirect · By Sigal Family Investments, LLC Disclosed balance after: 9,091 Read SEC document |
| April 30, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
SaleCommon Stock, $0.10 par value | 919 | $39.65 | $36,438.35 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 16 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Indirect · By Ruth L. Sigal Irrevocable Trust Disclosed balance after: 18,180 F6 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| April 30, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
SaleCommon Stock, $0.10 par value | 919 | $39.65 | $36,438.35 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 14 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Indirect · By C. Elliott Sigal 2012 Irrevocable Trust Disclosed balance after: 18,180 F6 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| April 30, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
SaleCommon Stock, $0.10 par value | 175,143 | $39.61 | $6,937,414.23 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 12 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,889 F1 · shares: Includes shares sold to cover exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. F4 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.60 to $39.67, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 30, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
SaleCommon Stock, $0.10 par value | 90,234 | $39.61 | $3,574,168.74 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 11 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,032 F1 · shares: Includes shares sold to cover exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. F4 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.60 to $39.67, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 30, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
SaleCommon Stock, $0.10 par value | 88,132 | $39.63 | $3,492,671.16 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 10 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,266 F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.62 to $39.65, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 30, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionCommon Stock, $0.10 par value | 103,500 | $25.45 | $2,634,075.00 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 9 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionCommon Stock, $0.10 par value | 202,405 | $24.74 | $5,007,499.70 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 8 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionExecutive Option (right to buy) · Derivative | 36,503 | $0.00 Strike: $24.74 | $0.00 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · derivative · entry 22 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,405 Underlying: Common Stock, $0.10 par value · 36,503 shares Expires 2016-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: One-third of the stock option award vested on each of the third, fourth and fifth anniversaries of the grant date, which was December 1, 2006. F9 · derivative.expiration_date: One-third of the stock option award vested on each of the third, fourth and fifth anniversaries of the grant date, which was December 1, 2006. Read SEC document |
| April 29, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionExecutive Option (right to buy) · Derivative | 11,092 | $0.00 Strike: $24.74 | $0.00 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · derivative · entry 21 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,908 Underlying: Common Stock, $0.10 par value · 11,092 shares Expires 2016-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: One-third of the stock option award vested on each of the third, fourth and fifth anniversaries of the grant date, which was December 1, 2006. F9 · derivative.expiration_date: One-third of the stock option award vested on each of the third, fourth and fifth anniversaries of the grant date, which was December 1, 2006. Read SEC document |
| April 29, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionExecutive Option (right to buy) · Derivative | 25,795 | $0.00 Strike: $22.73 | $0.00 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · derivative · entry 20 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 25,795 shares Expires 2016-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third and fourth anniversaries of the grant date, which was March 7, 2006. F8 · derivative.expiration_date: Twenty-five percent of the stock option award vested on each of the first, second, third and fourth anniversaries of the grant date, which was March 7, 2006. Read SEC document |
| April 29, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
SaleCommon Stock, $0.10 par value | 9,157 | $39.97 | $366,005.29 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 17 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Indirect · By Sigal Family Investments, LLC Disclosed balance after: 9,550 F5 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.90 to $40.00, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 29, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
SaleCommon Stock, $0.10 par value | 18,313 | $39.97 | $731,970.61 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 15 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Indirect · By Ruth L. Sigal Irrevocable Trust Disclosed balance after: 19,099 F5 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.90 to $40.00, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F6 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| April 29, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
SaleCommon Stock, $0.10 par value | 18,313 | $39.97 | $731,970.61 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 13 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Indirect · By C. Elliott Sigal 2012 Irrevocable Trust Disclosed balance after: 19,099 F5 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.90 to $40.00, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F6 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| April 29, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
SaleCommon Stock, $0.10 par value | 41,868 | $39.92 | $1,671,370.56 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 7 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,493 F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.90 to $40.00, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 29, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
SaleCommon Stock, $0.10 par value | 31,594 | $39.90 | $1,260,600.60 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 6 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,361 F1 · shares: Includes shares sold to cover exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. Read SEC document |
| April 29, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
SaleCommon Stock, $0.10 par value | 21,856 | $39.90 | $872,054.40 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 5 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,955 F1 · shares: Includes shares sold to cover exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. Read SEC document |
| April 29, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
SaleCommon Stock, $0.10 par value | 9,600 | $40.00 | $384,000.00 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 4 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,811 F1 · shares: Includes shares sold to cover exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. Read SEC document |
| April 29, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionCommon Stock, $0.10 par value | 11,092 | $24.74 | $274,416.08 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 3 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2013 Filed May 1, 2013 21:58 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionCommon Stock, $0.10 par value | 25,795 | $22.73 | $586,320.35 |
DisclosureSEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 2 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.